军事知识服务平台
医疗人工智能产品责任中的发展风险抗辩规则
摘要 从医疗技术进步需求、防止责任绝对化的制度效应等角度衡量,应将发展风险抗辩规则继续适用于医疗AI产品责任之中.应秉持优先保障安全利益、兼容发展利益、以技术进步推动实现高水平医疗安全的理念,对医疗AI场景下制造商的理性或注意义务作适度扩张设定,构建一套合理安全的发展风险抗辩规则体系.鉴于医疗行业的高敏感性,应将医疗AI产品责任中的发展风险抗辩事由设定为相对免责事由,令制造商对算法运行中的不可控环节履行警示告知义务,对缺陷产品负担召回等义务.应根据医疗AI产品的危险程度弹性把握合理发展风险的判定标准."黑箱"医疗的不可解释性不应该当然解释为合理发展风险;应倡导与促进社会安全价值观相一致的负责任的医疗技术创新,尽可能使医疗AI产品有效满足可解释性要求.
Abstract:
From the perspectives of advancing medical technology and preventing the insti-tutional effects of absolute liability,the development risk defense rules should continue to apply to product liability for medical AI.The principles of prioritizing safety interests,accommodating development interests,and promoting high-level medical safety through technological advance-ments should be upheld.The obligations of manufacturers regarding rationality or due diligence in medical AI scenarios should be appropriately expanded to construct a reasonable and secure system of rules for defending against development risks.Given the high sensitivity of the medical industry,defenses against development risks in medical AI product liability should be set as rel-ative exemptions,requiring manufacturers to fulfill their obligation to warn and inform about un-controllable aspects of algorithm operation and to recall defective products.The criteria for deter-mining reasonable development risks should be flexibly applied based on the degree of danger posed by medical AI products.The unexplainability of"black box"medicine should not be auto-matically interpreted as a reasonable development risk;responsible medical technology innovation consistent with social safety values should be advocated,and medical AI products should be made to effectively meet explainability requirements as much as possible.
刊 名 东方法学 ISTICPKU
年,卷(期): 2026, (2)
分类号: DF5
机标分类号: R-05 D923 F203
在线出版日期: 2026年6月3日